Team members


Arfan Ikram - WP2

Professor and department head of Epidemiology, and principal investigator of the Rotterdam Study, Erasmus MC Rotterdam

Professor Ikram completed his medical studies in 2005 and obtained an MSc degree in Clinical Epidemiology in 2003. He then embarked on a PhD, which he defended in 2009. After a short postdoc period and a year of clinical work at Radiology, professor Ikram finally made a permanent switch to pursue a full-time career in research at the end of 2010.

Professor Ikram’s interests in epidemiology lie in neurological disorders, especially dementia and Alzheimer’s disease. He is interested in the earliest origins of these diseases and how the brain is affected in structure and function during the preclinical phase. Furthermore, he has a specific methodological interest in questions regarding causality in observational data.

Within BBMRI, professor Ikram is involved in work package 2 and represents the Rotterdam Study.

Jasper Bovenberg - WP6

Legal Pathways Institute for Health and Bio-Law

Jeroen Belien - WP5


Hilleke Hulshoff Pol - WP 3


Folkert van Kemenade - WP4 / BBMRI-ERIC

Aad van der Lugt - WP3 / BBMRI-ERIC

Hoogleraar neuroradiologie en hoofd/halsradiologie bij het Erasmus MC

Wiro Niessen - WP3

Professor in Biomedical Image Analysis at Erasmus MC, Rotterdam Professor at Delft University of Technology

Gert-Jan van Ommen - BBMRI-ERIC


Marjanka Schmidt - WP6

Associate Professor (Group Leader), Genetic Epidemiologist, Netherlands Cancer Institute

Dr Schmidt is a genetic epidemiologist. Her research line focuses on the effects of genetic variants on risk of breast cancer subtypes, prognosis and long-term outcome of breast cancer, combining the areas of epidemiological and genetic research. One major promise is that advances in the genetics area will lead to precision prevention and medicine, where preventive and therapeutic interventions for complex diseases can be individually tailored to a person's genetic profile. Dr Schmidt’s group aims to contribute to the genome-based applications in health care practice by elucidating the role of germline variants in breast cancer risk and prognosis by molecular and genetic epidemiological studies, as well as addressing ethical, legal and societal aspects of genomics.

Dr Schmidt is responsible for the ELSI (ethical legal and social issues) component of BBMRI, including the ELSI Servicedesk. Dr Schmidt is also the secretary of the COREON (Committee Regulation Research), a subcommittee of the Federa.

Eline Slagboom - WP2


Morris Swertz - WP 5


Gerlof Valk - WP 4


Stefan Willems - WP 4


Michel Wouters - WP 4


Jan-Willem Boiten - WP5

Program manager Health-RI, TraIT & Data4lifescience at Lygature

Jan-Willem Boiten received his PhD in organic chemistry (computer-aided synthesis methods) at the University of Nijmegen in 1995. Subsequently, he joined the pharmaceutical industry in several project management and other managerial positions within research informatics. In 2011, Jan-Willem joined the Center for Translational Molecular Medicine (CTMM; now Lygature) to become the program manager for the TraIT (Translational research IT) project, a national IT infrastructure for storing, sharing, and analyzing translational research data. Next to his role in TraIT, Jan-Willem is coordinating the research IT collaboration between the Dutch UMCs, Data4LifeSciences, and is part of the management team for the overarching infrastructure for health research in The Netherlands, Health-RI.

Within BBMRI-NL, Jan-Willem is co-leading WP5 (Common Services for IT) with a specific focus on the integration of the BBMRI-NL services into the Health-RI services.